STAT

3 min. di lettura

Although Sen. Ted Cruz (R-Texas) is quarantined at home after coming into contact with someone who tested positive for Covid-19, the lawmaker plans to introduce a bill to permit the Food and Drug Administration to approve any drug, device, or vaccine

Popular Science

2 min. di lettura

Don't let fear keep your pup covered in fleas. DepositPhotos Last week, the U.S. Food and Drug Administration put out a frightening warning for pet owners and vets: certain flea and tick medications—isoxazoline class drugs—have the potential to cause

NPR

3 min. di lettura

President Trump spoke about the effort during a briefing at the White House. He also expressed interest in the government possibly taking an equity stake in companies as part of a big stimulus.

NPR

4 min. di lettura

In China, drug manufacturers are getting back to work. But supply chain disruptions could still lead to drug shortages down the road.

NPR

4 min. di lettura

As the U.S. prepares for what will likely be the largest vaccination program in its history, the Trump administration plans to loan $590 million to a Connecticut company with a novel technology.

Popular Science

2 min. di lettura

King Bio, a homeopathic drug company, is recalling 32 of its children’s pain-relievers. According to the FDA, a “small percentage” of those products tested positive for bacterial contamination during regular, random testing by King Bio. Deposit Photo

The Atlantic

4 min. di lettura

The frequency of alerts and the number of drugs in undersupply are shocking developments in a rich country.

STAT

3 min. di lettura

Hospital leaders must step up and support new models that nourish the drug manufacturing market and bring it back to life.

NPR

3 min. di lettura

Health and Human Services outlined two pathways for importing the drugs to the U.S., a plan Secretary Alex Azar says is intended to "lower prices and reduce out of pocket costs for American patients."

STAT

3 min. di lettura

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest this time around. We plan to hang with a couple of our

STAT

3 min. di lettura

Given the approach FDA is proposing on state-sponsored drug importation, it's a long shot that states will see significant savings, or even enough to justify the cost of setting up…

STAT

2 min. di lettura

In an early but striking move, the Trump administration is opening the door to possibility of importing drugs in limited cases.

STAT

3 min. di lettura

Many drug labels are out of date. Congress should give the FDA the authority to encourage drug manufacturers to keep this essential information up to date.

Los Angeles Times

3 min. di lettura

If there's anyone in the United States who can see the future of medicine, it's Dr. Janet Woodcock. As the director of the Center for Drug Evaluation and Research at the Food and Drug Administration, Woodcock is responsible for making sure that new m

STAT

3 min. di lettura

In theory, it's easier to bring medical devices to the market than drugs. But getting a device approved in the U.S. is often difficult.

STAT

4 min. di lettura

A new report from the U.S. National Academies, "Regulating Medicines in a Globalized World," shows how regulatory authorities can work together and avoid duplication.

STAT

2 min. di lettura

After learning an ingredient used to make a widely prescribed heart drug contained a substance linked to cancer, the Food and Drug Administration is now testing all drugs in that class for traces of the toxic material. The probe into angiotensin II r

Kiplinger

1 min. di lettura

[Question] I keep hearing that many promising new drugs for cancer and other diseases are not legally available in this country because of excessively long and expensive approval processes at the U.S. Food and Drug Administration. What can be done to

STAT

3 min. di lettura

400,000 new jobs have been created in the U.S. domestic manufacturing sector. We must focus this momentum and begin bringing pharmaceutical manufacturing jobs back to the U.S.

STAT

3 min. di lettura

Drug shortages can have profound adverse consequences. Identifying their root causes and devising workable solutions for them will require a multi-stakeholder effort with more accountability and greater agility than we've…

STAT

3 min. di lettura

Adopting H.R. 3 to lower drug costs would be a pyrrhic victory. While it could reduce some drug prices for some people, in the long run it would reduce the…

Los Angeles Times

2 min. di lettura

China has become the world's largest producer and exporter of "active pharmaceutical ingredients," the base components drug companies use to manufacture most of the medications we rely on. China's dominance puts both the health of Americans and our n

Los Angeles Times

4 min. di lettura

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan. So it was with more than a little concern that he recently learned the Chinese supplier of the drug's active ingredient for years had b

STAT

2 min. di lettura

U.S. senators have blasted Novartis for data manipulation involving one of its drugs, saying it "smacks of the pharmaceutical industry’s privilege and greed."

Los Angeles Times

3 min. di lettura

The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long opposed by many Republicans. This latest initiative w

Los Angeles Times

3 min. di lettura

If you believe that the federal government and the pharmaceutical manufacturers are effectively working together to protect patients from unsafe drugs, you might want to consider a trove of records released in an Ohio court case last month. The docum

NPR

2 min. di lettura

Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.

NPR

2 min. di lettura

Changes in the way the Food and Drug Administration reviews new medicines means that there are more cures and treatments on the market. But there's also less proof the drugs are safe and effective.

Manhattan Institute

2 min. di lettura

Making available other countries’ already-approved medications would achieve far more than giving patients access to experimental drugs.

STAT

1 min. di lettura

Immunomedics' antibody drug conjugate to treat women with an aggressive form of breast cancer could not be approved at this time, the FDA said.